The Miami Heat are not committing to anything when it comes to Chris Bosh’s playing status. An issue that has been recently discussed is the question of whether Bosh should discontinue blood thinners or continue with that treatment.
If the 11-time NBA All-Star stops taking the medication this summer, there should be no reason why he would not be able to suit up next season.
Even if he stayed with his current treatment, the Texas native has gone back and forth with Heat offiicials to argue for his activation on the roster. This agreement would hinge on a new medication that would cycle through his system by game-time.
The new medicine would lessen or remove the risk of playing basketball while on blood thinners. Miami has been lukewarm on the idea, which angered the big-man after the All-Star break.
Pat Riley has said that the Heat won’t make a decision on their franchise player until the fall during his end of season address. However, it is known that the forward badly wants to play and believes that his club should clear him for basketball activities.
Some in the Bosh camp are skeptical of the franchise’s motives. They wonder if the team would be trying to clear cap space in South Beach for the free agent bonanza coming next summer.
League protocol states that he can be removed from Miami’s cap if: “a doctor that is jointly selected by the league and players association agree his condition is career-ending, or severe enough to put him at risk if he continues playing.”
Further complicating matters is the fact that if the All-Star takes the floor before February 9 of next year, his salary could not be moved from the Heat’s cap for a full calendar year.
The only thing to do is wait and see what the doctors say and for both parties, the answers cannot come quickly enough.